Found 13 matching trials
Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer PHASE1 This phase I trial studies the side effects and the best dose of Z-endoxife...
Show More Status
Active Not Recruiting
Location
Mayo Clinic in Arizona
Learn More & Join Trial
Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer PHASE2 This randomized phase II trial studies how well tamoxifen citrate works com...
Show More Status
Active Not Recruiting
Location
Southern Cancer Center PC-Providence
Learn More & Join Trial
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer PHASE2 This open-label research study is studying (Z)-endoxifen as a possible trea...
Show More Status
Active Not Recruiting
Location
Mayo Clinic Arizona
Learn More & Join Trial
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer PHASE2 The purpose of this study is to further advance the ability to practice per...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment PHASE2 The goal of this trial is to see if active surveillance monitoring and horm...
Show More Location
Berkeley Outpatient Center
Learn More & Join Trial
Therapeutic Dose Monitoring (TDM) of Tamoxifen PHASE2 Tamoxifen is a potent and effective drug reducing the risk of dying from br...
Show More Location
Karolinska University Hospital
Learn More & Join Trial
Genotyping and Phenotyping of CYP2D6 Breast Cancer Patients on Tamoxifen N/A This study is an observational study to determine phenotype and genotype of...
Show More Location
Dharmais hospital
Learn More & Join Trial
Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients PHASE2 In hormone-receptor positive breast cancer or DCIS (ductal carcinoma in sit...
Show More Location
Gemeinschaftspraxis für Gynäkologie und Geburtshilfe Salzgitter
Learn More & Join Trial
The POWER Trial: Personalised Dose Optimisation With Adjuvant Tamoxifen Therapy in Breast cancER PHASE3 In Sweden, approximately 7000 women are diagnosed with hormone-sensitive br...
Show More Location
S:a Älvsborgs Sjukhus
Learn More & Join Trial
Endoxifen in Adults With Hormone Receptor Positive Solid Tumors PHASE1 Background:
* Some types of cancer cells that have hormone receptors on th...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial